bucladesine and Arrhythmias, Cardiac

bucladesine has been researched along with Arrhythmias, Cardiac in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (77.78)	18.7374
1990's	2 (22.22)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daries, P; Lubbe, WF; Muller, C; Nathan, D; Opie, LH	1
Kang, JX; Leaf, A	1
Kaplan, D; Khananshvili, D; Manoach, M; Shainberg, A; Tribulova, N; Varon, D; Zinman, T	1
Lubbe, WF; Nathan, D; Opie, LH	1
Bricknell, OL; Lubbe, WF; Podzuweit, HO	1
Kane, KA; Morcillo-Sanchez, EJ; Parratt, JR; Rodger, IW; Shahid, M	1
Coetzee, WA; Opie, LH; Saman, S	1
Bhargava, KP; Saxena, PR	1

Reviews

1 review(s) available for bucladesine and Arrhythmias, Cardiac

Article	Year
Biochemical aspects of arrhythmogenesis and ventricular fibrillation. The American journal of cardiology, 1979, Volume: 43, Issue:1 Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bucladesine; Catecholamines; Cyclic AMP; Fatty Acids, Nonesterified; Glycolysis; Humans; Hyperkalemia; Lactates; Membrane Potentials; Myocardial Infarction; Myocardium; Potassium; Purkinje Fibers; Theophylline; Ventricular Fibrillation	1979

Article

Year

Biochemical aspects of arrhythmogenesis and ventricular fibrillation.

The American journal of cardiology, 1979, Volume: 43, Issue:1

Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bucladesine; Catecholamines; Cyclic AMP; Fatty Acids, Nonesterified; Glycolysis; Humans; Hyperkalemia; Lactates; Membrane Potentials; Myocardial Infarction; Myocardium; Potassium; Purkinje Fibers; Theophylline; Ventricular Fibrillation

1979

Other Studies

8 other study(ies) available for bucladesine and Arrhythmias, Cardiac

Article	Year
Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation. Advances in cyclic nucleotide research, 1980, Volume: 12 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Disease Models, Animal; Heart; Heart Ventricles; Myocardial Contraction; Potassium; Receptors, Adrenergic; Receptors, Adrenergic, beta; Swine; Theophylline	1980
Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochemical and biophysical research communications, 1995, Mar-17, Volume: 208, Issue:2 Topics: Animals; Animals, Newborn; Arrhythmias, Cardiac; Bucladesine; Cells, Cultured; Cholera Toxin; Death, Sudden; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Fish Oils; In Vitro Techniques; Isoproterenol; Myocardial Contraction; Rats; Tachycardia	1995
The role of sarcoplasmic reticulum in the protective effect of class III drugs against Ca2+ overload. General physiology and biophysics, 1999, Volume: 18 Suppl 1 Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Bucladesine; Calcium; Cells, Cultured; Cyclopropanes; Heart; Humans; Ion Transport; Myocardium; Rats; Sarcoplasmic Reticulum; Sotalol; Thapsigargin	1999
Cyclic AMP as a determinant of vulnerability to ventricular fibrillation in the isolated rat heart. Cardiovascular research, 1976, Volume: 10, Issue:6 Topics: Animals; Arrhythmias, Cardiac; Bucladesine; Butyrates; Catecholamines; Coronary Circulation; Heart Rate; In Vitro Techniques; Rats; Ventricular Fibrillation	1976
[Choice for the treatment of congestive heart failure]. Journal of cardiology. Supplement, 1989, Volume: 20 Topics: Administration, Oral; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Blood Flow Velocity; Bucladesine; Cardiac Output; Cardiotonic Agents; Echocardiography, Doppler; Electrocardiography, Ambulatory; Heart Failure; Heart Rate; Humans; Physical Endurance; Pulmonary Veins; Vasodilator Agents	1989
The relationship between coronary artery occlusion-induced arrhythmias and myocardial cyclic nucleotide levels in the anaesthetized rat. British journal of pharmacology, 1985, Volume: 84, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Anesthesia; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Cyclic GMP; Dibutyryl Cyclic GMP; Heart; Male; Myocardium; Quinazolines; Rats; Rats, Inbred Strains	1985
Inhibition by simulated ischemia or hypoxia of delayed afterdepolarizations provoked by cyclic AMP: significance for ischemic and reperfusion arrhythmias. Journal of molecular and cellular cardiology, 1988, Volume: 20, Issue:2 Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Bucladesine; Coronary Disease; Cyclic AMP; Electric Stimulation; Guinea Pigs; Heart; Hypoxia; Isoproterenol; Perfusion	1988
Central beta-adrenoceptor sites and ouabain action. Pharmacological research communications, 1974, Volume: 6, Issue:4 Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Bucladesine; Catecholamines; Cats; Cerebral Ventricles; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Female; Heart Rate; Hexamethonium Compounds; Hydroxydopamines; Injections; Isoproterenol; Male; Methyl Ethers; Ouabain; Quinolizines; Receptors, Adrenergic; Stereotaxic Techniques; Tachyphylaxis; Theophylline; Vagotomy; Vagus Nerve	1974